Received Jul 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | E4A39 | — |
expired dose administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 17-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number E4A39, expiry date 30-JUN-2025) for prophylaxis. On 11-JUL-2025, the patient received Menveo. On 11-JUL-2025, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: expired dose administered). The outcome of the expired vaccine used was not applicable. Additional Information: GSK receipt date: 11-JUL-2025 The nurse manager explained that they administered an expired dose of Menveo (1-vial) to the patient which led to, expired vaccine used.